{"ticker": {"uuid": "ffdd7424-f855-487b-9e06-56435a3555d1", "symbol": "4552", "name": "JCR Pharmaceuticals Co., Ltd.", "exchange": "JPX", "country": "JP", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "JCR Pharmaceuticals Sets 2026\u20132027 Timeline to Launch Givinostat for Duchenne Muscular Dystrophy in Japan", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7gFBVV95cUxPcnBkaFNRQ0VSWHFybVRxTnVfT0llM21yb1hTdkZHcWJUSDhkZV9mbjVYSUw0bENhbzFZbGVTM0ZwT25pU3Q0MHJwRFRkQU84TVVxY0dPUUdKNlNlY1hSek0zcUJWdVlWM3E5UkkzTGNSUHZ1bnhoOXhsWTJ0SHFnRVJwMjlrLXNMcV9WbjNGWjJETGpSSkI2UTgtcVN6aUt4cExSQVMyYVB3X3hQZGdIdkRHOGpJV0RsLS1EZ3poLUxUcmtqRy1Oa04zWUpvdUp0SlRkVDJmZERvYTNrZzZJS1pFc1Y1OUhqMFhURk5B?oc=5", "source_name": "TipRanks", "published_at": "2026-07-15T00:00:14+00:00", "published_display": "15 Jul 2026 00:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of JCR Pharmaceuticals Co., Ltd. \u2013 FWB:JCR", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOQ1JBaVlSc29LMXJkcm93SDJwX21EU2wwbVRuclhHOFczUDN0cl9WdzVaLUhKYWY4aWdhMUFSWGMtZ19TS3NWV2hEOXFfRmoyd2Y1NUlxZWpNV25LZ2YxcnZZY3JQWkN6RTJCWGg2d09MOHU4cW0yNk9ULUtHLTdURl9PZkNzTjJycXE3bFNEQWhDVERVamthQQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-13T09:28:36+00:00", "published_display": "13 Jul 2026 09:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of JCR Pharmaceuticals Co., Ltd. \u2013 TSE:4552", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNWXRiTTFwMmx0b1cyaVhyNWF2czdELXB3V3VsOFg1cjVhQndrLUJoOFEzYjdiUzdyekx6WVVnWXZRc2VpSUFpdnBZRUhlN0xhbnR5WXZzbVZNU3hRY0ZOaHFHSXdLZFYya3NMS2RRaFpUWDQxbjhlQXRmY055REktcWpZQkVUc29FRjVicVdYS3hDZndwNVpsdw?oc=5", "source_name": "TradingView", "published_at": "2026-07-08T00:29:35+00:00", "published_display": "08 Jul 2026 00:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "JCR Pharmaceuticals Sets 2026\u20132027 Timeline to Launch Givinostat for Duchenne Muscular Dystrophy in Japan", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7gFBVV95cUxPcnBkaFNRQ0VSWHFybVRxTnVfT0llM21yb1hTdkZHcWJUSDhkZV9mbjVYSUw0bENhbzFZbGVTM0ZwT25pU3Q0MHJwRFRkQU84TVVxY0dPUUdKNlNlY1hSek0zcUJWdVlWM3E5UkkzTGNSUHZ1bnhoOXhsWTJ0SHFnRVJwMjlrLXNMcV9WbjNGWjJETGpSSkI2UTgtcVN6aUt4cExSQVMyYVB3X3hQZGdIdkRHOGpJV0RsLS1EZ3poLUxUcmtqRy1Oa04zWUpvdUp0SlRkVDJmZERvYTNrZzZJS1pFc1Y1OUhqMFhURk5B?oc=5", "source_name": "TipRanks", "published_at": "2026-07-15T00:00:14+00:00", "published_display": "15 Jul 2026 00:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of JCR Pharmaceuticals Co., Ltd. \u2013 FWB:JCR", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOQ1JBaVlSc29LMXJkcm93SDJwX21EU2wwbVRuclhHOFczUDN0cl9WdzVaLUhKYWY4aWdhMUFSWGMtZ19TS3NWV2hEOXFfRmoyd2Y1NUlxZWpNV25LZ2YxcnZZY3JQWkN6RTJCWGg2d09MOHU4cW0yNk9ULUtHLTdURl9PZkNzTjJycXE3bFNEQWhDVERVamthQQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-13T09:28:36+00:00", "published_display": "13 Jul 2026 09:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of JCR Pharmaceuticals Co., Ltd. \u2013 TSE:4552", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNWXRiTTFwMmx0b1cyaVhyNWF2czdELXB3V3VsOFg1cjVhQndrLUJoOFEzYjdiUzdyekx6WVVnWXZRc2VpSUFpdnBZRUhlN0xhbnR5WXZzbVZNU3hRY0ZOaHFHSXdLZFYya3NMS2RRaFpUWDQxbjhlQXRmY055REktcWpZQkVUc29FRjVicVdYS3hDZndwNVpsdw?oc=5", "source_name": "TradingView", "published_at": "2026-07-08T00:29:35+00:00", "published_display": "08 Jul 2026 00:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 72, "total_relevant": 3, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 3, "score": 50, "total": 3, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 477.0, "latest_week": "2026-07-10", "one_week_move": 4.8, "four_week_move": 6.2, "twelve_week_move": -22.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.303039, "market_dynamics_buy_signal": false, "relative_strength": -40.721885, "fair_value_gap": -31.9, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 45.8684, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+4.8% over one week, +6.2% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 57, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 2}, {"label": "TipRanks", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+4.8% over one week, +6.2% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "JCR Pharmaceuticals Sets 2026\u20132027 Timeline to Launch Givinostat for Duchenne Muscular Dystrophy in Japan"}], "updated_at": "2026-07-17T15:04:00.848844+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}